By
Drug Target Review2025-04-11T08:30:52
Researchers at UTHealth Houston have initiated a new stem cell therapy trial aimed at reducing neuroinflammation to prevent Alzheimer's disease before symptoms emerge, an approach that could revolutionise treatment strategies, offering new hope for at-risk individuals.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:04:00Z
2026-06-22T07:00:00Z
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-04-04T15:03:09
Sponsored by Agilent
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-07-11T16:13:06
Sponsored by Agilent
2024-01-19T07:40:55
Sponsored by Euretos
Site powered by Webvision Cloud